WHO Approves First Mpox Vaccine for Limited Use in Selected Countries
WHO – The World Health Organization has taken a pivotal step in the fight against mpox by approving the MVA-BN vaccine for limited use. This vaccine, developed by Bavarian Nordic A/S, is now the first mpox vaccine to be prequalified by the WHO, making it a crucial tool in controlling mpox outbreaks, particularly in Africa. … Read more